Home・Listă Acțiuni・Charles River Laboratories International Inc

Charles River Laboratories International Inc

Închisă

SectorSănătate

298.97 0.96

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

287.75

Maxim

298.95

Indicatori cheie
By Trading Economics
Venit	14M -760K
Vânzări	8.2M 1B
EPS	3.02
Marjă de profit	-0.076
Angajați	18,300
EBITDA	87M 151M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	-3.57% downside

Dividende
By Acuity
Următoarele câștiguri	4 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	2.5B 14B
Deschiderea anterioară	298.01
Închiderea anterioară	298.97

Sentimentul știrilor

By Acuity

50%

150 / 340 Clasament în Healthcare

Charles River Laboratories International Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 aug. 2026, 19:16 UTC

Correlated Moves

Charles River Laboratories is trading roughly flat amid a notable decline in Agilent Technologies. Market focus is on upcoming events, including a Federal Reserve speech.

21 aug. 2026, 23:01 UTC

Charles River Laboratories shares declined in after-market trading, amid broader market volatility tied to rising U.S. Treasury yields and inflation concerns.

20 aug. 2026, 19:41 UTC

News

Charles River Laboratories partners with Medigen to develop a multivalent enterovirus vaccine, supporting regulatory readiness and non-clinical studies. Shares are trading higher.

19 aug. 2026, 23:56 UTC

Charles River Laboratories shares are higher in after-market trading, reaching a notable increase since Wednesday's close and positioning near the upper end of its one-month range.

17 aug. 2026, 19:26 UTC

Charles River Laboratories shares are higher today, continuing an upward trend since Friday's close. The stock remains near the top of its one-month trading range.

14 aug. 2026, 19:46 UTC

Charles River Laboratories shares are lower amid broader market declines following a drop in U.S. retail sales, indicating potential weakening consumer demand.

13 aug. 2026, 19:52 UTC

Correlated Moves

Charles River Laboratories shares are lower today amid rising jobless claims and volatility, reflecting a decline since Wednesday's close.

12 aug. 2026, 20:51 UTC

Charles River Laboratories is higher in after-market trading, reflecting positive momentum despite no specific news. Broader market dynamics appear to support this resilience.

11 aug. 2026, 19:56 UTC

Charles River Laboratories International Inc. shares are trading higher today, maintaining a position above the 20-day moving average amid routine price movements.

10 aug. 2026, 19:16 UTC

News

Charles River Laboratories shares rise as TD Cowen and Mizuho raise price targets to $300 and $264, respectively. The stock shows notable strength since Friday.

7 aug. 2026, 19:51 UTC

News

Morgan Stanley raised its price target on Charles River Laboratories to $300, maintaining an Overweight rating as shares move higher since Thursday's close.

6 aug. 2026, 22:51 UTC

Shares of Charles River Laboratories International Inc. are lower in after-market trading, continuing a decline from Thursday's close despite being above its 20-day moving average.

5 aug. 2026, 23:56 UTC

Charles River Laboratories is higher in after-market hours, recovering from session lows. Broader market sentiment is affected by a disappointing ADP employment report.

4 aug. 2026, 19:16 UTC

Correlated Moves

Charles River Laboratories is rising amid positive momentum in the small-cap market, supported by a drop in crude oil prices that eases inflation concerns.

3 aug. 2026, 22:06 UTC

Charles River Laboratories shares are slightly higher in after-hours trading, supported by stronger-than-expected manufacturing data showing a rise in the PMI for July.

31 iul. 2026, 19:46 UTC

Correlated Moves

Charles River Laboratories reported first-quarter revenue of $1.02 billion and adjusted EPS of $2.06, but shares are lower amid broader market declines.

30 iul. 2026, 23:01 UTC

Shares of Charles River Laboratories are higher in after-market trading, reaching a peak above Thursday's close and remaining strong relative to recent trends.

29 iul. 2026, 19:18 UTC

Correlated Moves

Charles River Laboratories is lower today amid broader market declines and investor caution ahead of the Federal Reserve's monetary policy announcement.

28 iul. 2026, 18:02 UTC

Charles River Laboratories is trading higher today, continuing a strong rally since Monday. The stock remains above its 20-day moving average.

27 iul. 2026, 17:36 UTC

News

Correlated Moves

Charles River Laboratories is trading lower today, reflecting a decline since Friday. The company announced a collaboration with Arovella Therapeutics for GMP sequencing services.

23 iul. 2026, 00:01 UTC

Charles River Laboratories is higher in after-hours trading, maintaining a cumulative gain since Wednesday amid no specific news to explain the movement.

22 iul. 2026, 22:01 UTC

Charles River Laboratories shares are higher in after-hours trading, reflecting a notable increase since Wednesday's close and positioning above the 20-day moving average.

21 iul. 2026, 21:01 UTC

Charles River Laboratories shares moved lower in after-market trading, continuing a steady decline since Tuesday's close amid broader market concerns.

20 iul. 2026, 21:01 UTC

Shares of Charles River Laboratories International Inc are lower in after-market trading, continuing a trend of declines with no specific news to explain the movement.

Comparație

Modificare preț

Charles River Laboratories International Inc Așteptări

Obiectiv de preț

By TipRanks

-3.57% jos

Prognoză pe 12 luni

Medie 284.64 USD -3.57%

Maxim 310 USD

Minim 219 USD

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCharles River Laboratories International Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

13 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 13 analiști care au acordat evaluări ale acțiunilor Charles River Laboratories International Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

150 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Charles River Laboratories International Inc

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.